Sensydia
ApprovedThe Sensydia Cardiac Performance System (CPS) enables the rapid assessment of critical care and heart failure patients by non-invasively measuring key hemodynamic metrics.
Founded
2017
Focus
Medical DevicesCardiovascularDiagnostics
About
The Sensydia Cardiac Performance System (CPS) enables the rapid assessment of critical care and heart failure patients by non-invasively measuring key hemodynamic metrics.
Funding History
2Total raised: $10.5M
Series A$8MLacuna Healthcare VenturesJun 15, 2021
Seed$2.5MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2017
LocationLos Angeles, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile